Related Experiment Video
Updated: May 31, 2026
10:09
A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)
Published on: March 15, 2017
Biological targets of isothiocyanates
Kristin K Brown1, Mark B Hampton
1Free Radical Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand.
Biochimica Et Biophysica Acta
|June 28, 2011
Summary
Isothiocyanates, natural compounds with anti-cancer properties, may work by altering proteins and cellular balance. Further research is needed to identify all molecular targets for drug development.
Area of Science:
- Phytochemistry
- Molecular Biology
- Pharmacology
Background:
- Isothiocyanates are phytochemicals with diverse biological activities.
- They exhibit antioxidant, pro-apoptotic, and anti-inflammatory effects.
- Evidence suggests anti-cancer and anti-inflammatory roles for isothiocyanates.
Purpose of the Study:
- This review focuses on the molecular targets of isothiocyanates.
- It explores how modifications of these targets lead to biological responses.
Main Methods:
- Literature review of isothiocyanate molecular targets.
- Analysis of structure-activity relationships.
- Discussion of target identification techniques.
Main Results:
- Isothiocyanates may act via direct protein modification or indirect disruption of redox homeostasis.
- Some target proteins have been identified.
- Novel targets require further investigation using advanced techniques.
Conclusions:
- Target identification is crucial for rational drug design and understanding isothiocyanate therapeutic potential.
- Identifying targets provides insight into the pathways regulated by isothiocyanates.
- Further research, including site-directed mutagenesis, is needed to determine the significance of specific modifications.
Related Concept Videos
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...